학술논문
Intermediate-Acting Isophane vs Long-Acting Insulins: What’s the Real Cost?
Document Type
Periodical
Author
Source
Clinical Advisor. September 1, 2022
Subject
Language
English
ISSN
1524-7317
Abstract
Switching from long-acting insulin (LAI), such as glargine or detemir, to intermediate-acting isophane (NPH) insulin could save the average older patient in the United States using 1 vial per month [...]